-+ 0.00%
-+ 0.00%
-+ 0.00%

INNOCARE PHARMA - SOFICITINIB ACHIEVES STATISTICALLY SIGNIFICANT PRIMARY AND MULTIPLE SECONDARY ENDPOINTS

路透·07/15/2026 11:54:25

登录查看新闻详情